- Home
- BTAI vs JRSH Comparison
BTAI vs JRSH Comparison
Compare BTAI & JRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- JRSH
- Stock Information
- Founded
- BTAI 2017
- JRSH 2016
- Country
- BTAI United States
- JRSH United States
- Employees
- BTAI N/A
- JRSH N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- JRSH Apparel
- Sector
- BTAI Health Care
- JRSH Consumer Discretionary
- Exchange
- BTAI Nasdaq
- JRSH Nasdaq
- Market Cap
- BTAI 48.3M
- JRSH 41.7M
- IPO Year
- BTAI 2018
- JRSH 2018
- Fundamental
- Price
- BTAI $2.07
- JRSH $3.40
- Analyst Decision
- BTAI Buy
- JRSH Strong Buy
- Analyst Count
- BTAI 5
- JRSH 1
- Target Price
- BTAI $32.80
- JRSH $4.00
- AVG Volume (30 Days)
- BTAI 1.0M
- JRSH 298.9K
- Earning Date
- BTAI 11-13-2025
- JRSH 11-11-2025
- Dividend Yield
- BTAI N/A
- JRSH 5.88%
- EPS Growth
- BTAI N/A
- JRSH N/A
- EPS
- BTAI N/A
- JRSH 0.07
- Revenue
- BTAI $868,000.00
- JRSH $144,505,598.00
- Revenue This Year
- BTAI N/A
- JRSH $7.62
- Revenue Next Year
- BTAI $614.78
- JRSH $8.35
- P/E Ratio
- BTAI N/A
- JRSH $51.82
- Revenue Growth
- BTAI N/A
- JRSH 17.11
- 52 Week Low
- BTAI $1.17
- JRSH $2.81
- 52 Week High
- BTAI $13.28
- JRSH $4.17
- Technical
- Relative Strength Index (RSI)
- BTAI 34.40
- JRSH 60.37
- Support Level
- BTAI $2.14
- JRSH $3.33
- Resistance Level
- BTAI $2.46
- JRSH $3.48
- Average True Range (ATR)
- BTAI 0.17
- JRSH 0.09
- MACD
- BTAI 0.00
- JRSH 0.02
- Stochastic Oscillator
- BTAI 2.64
- JRSH 71.43
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About JRSH Jerash Holdings (US) Inc.
Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.